AtriCure (ATRC) Tops Q2 EPS by 22c
Tweet
Share
E-mailGet Alerts ATRC Hot Sheet
Price: $27.98 -2.51%
Revenue Growth %: +11.7%
Financial Fact:
Basic and diluted net loss per share: -0.21
Today's EPS Names:
FOMI, FLES, IMMR, More
Revenue Growth %: +11.7%
Financial Fact:
Basic and diluted net loss per share: -0.21
Today's EPS Names:
FOMI, FLES, IMMR, More
Join SI Premium – FREE
AtriCure (NASDAQ: ATRC) reported Q2 EPS of ($0.01), $0.22 better than the analyst estimate of ($0.23). Revenue for the quarter came in at $51.8 million versus the consensus estimate of $49.9 million.
GUIDANCE:
AtriCure sees FY2018 revenue of $193-197 million, versus the consensus of $195 million.
For earnings history and earnings-related data on AtriCure (ATRC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Constellation Brands (STZ) Tops Q1 EPS by 18c
- BNP Paribas Exane Starts Klepierre (LI:FP) (KLPEF) at Neutral
- Nike (NKE) PT Lowered to $72 at Bernstein SocGen Group
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
